James Antal - Director, Cleveland Biolabs Inc

As of April 24, 2015


James Antal Net Worth

  • Net worth is estimated to be at least $1.69M
  • Owns at least 35,258 units of Cleveland Biolabs Inc stock

James Antal Trading

  • Largest purchase of shares was 5,300 units , worth over $11.98K on July 3, 2012
  • In total has made about 16 transactions over 8 years
  • Usually trades in June, with the busiest year in 2010, 2011 and 2012
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

James Antal Mailing Address

  • Mailing address is 30952 Steeplechase Drive San Juan Capistrano CA 92675 CA

Cleveland Biolabs Inc Executive Compensation

Name
Year
Salary
Other Compensation
Total
Langdon L. Miller 2019 $73,725 - $77,625
Langdon L. Miller 2018 $119,550 - $119,550
Andrei Gudkov 2019 $66,138 - $66,138
Andrei Gudkov 2018 $110,941 - $110,941
Christopher Zosh 2019 $92,463 $11,031 $103,494
Christopher Zosh 2018 $73,031 $9,161 $82,192
Yakov Kogan 2019 $264,323 $50,607 $314,930
Yakov Kogan 2018 $276,000 $10,800 $286,800
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1318641/000143774920023024/cbli20201029_def14a.htm

Cleveland Biolabs Inc Insider Trading

  • The most recent transaction was 1,891 units bought on February 27, 2015 by Randy S Saluck worth over $6.47K
  • In the last 8 years, insiders at Cleveland Biolabs Inc sold an estimated value of $1.16M and bought an estimated value of $275.69K
  • The most active traders are Yakov Kogan, Chief Executive Officer,  Andrei Gudkov, Chief Scientific Officer,  and Michael Fonstein, President
  • Insider trading is most common in June, with the busiest year in 2010
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1